On a standard Estrace protocol, most women can expect their uterine lining to reach 7 mm or more within about 10 to 14 days. Growth typically starts slowly in the first few days and accelerates as estrogen levels build, with the lining thickening roughly 0.5 to 1 mm per day during the peak growth window. The exact speed varies significantly from person to person, and your clinic will monitor progress with ultrasound to confirm you’re on track.
What Estrace Does to Your Lining
Estrace is a brand of estradiol, the same form of estrogen your body produces naturally during the first half of a menstrual cycle. When you take it for a frozen embryo transfer (FET), it replaces your body’s own hormonal signals and stimulates the cells of the endometrium to divide, thicken, and develop new blood vessels. The goal is to build a lining that closely mimics what a natural cycle would produce right before ovulation.
Treatment usually begins on day 2 of your menstrual cycle. A standard dose is 6 mg per day, split into morning and evening doses, though some protocols start at 4 mg per day. You’ll typically take it for 10 to 14 days before your first lining check, which usually falls around day 9 or 10 of estrogen use.
The Target Thickness
Your clinic is looking for a lining of at least 7 mm before adding progesterone and scheduling your transfer. A large study published in Frontiers in Cell and Developmental Biology found that 10 to 11.9 mm is clinically considered the ideal range for implantation, with the highest live birth rates clustering around that thickness. That said, the relationship between thickness and success isn’t a simple cutoff. Linings of 7 to 8 mm can still support pregnancy, and going above 12 mm doesn’t necessarily improve your odds further.
Thickness isn’t the only thing your doctor is evaluating. The pattern of the lining on ultrasound matters too. A “trilaminar” pattern, where the lining shows three distinct layers on the screen, is associated with roughly three times better odds of pregnancy compared to a lining that appears uniform or homogeneous. Both thickness and pattern are independent predictors of success, so your doctor is ideally looking for both a thick and well-structured lining before moving forward.
Oral vs. Vaginal Estrace
Estrace can be taken orally (swallowed) or vaginally (inserted as a tablet). Most protocols start with oral dosing, but if your lining isn’t responding well by day 9 or 10, your doctor may switch you to vaginal administration. Vaginal estradiol delivers more of the hormone directly to the uterus and produces higher local tissue levels, which often jumpstarts growth in women who stalled on oral dosing.
Research from Fertility and Sterility found that among women whose linings measured under 7 mm on oral estradiol, over 91% reached adequate thickness after switching to vaginal administration. So if your lining is growing slowly on pills, a switch to vaginal dosing is a well-established next step, not a sign that something is seriously wrong.
Why Some Linings Grow Slowly
Not everyone’s lining responds to Estrace at the same pace, and several factors can slow things down. Age is one of the most common: the endometrium naturally becomes thinner and less responsive to estrogen over time. Women who have had uterine procedures like D&Cs (dilation and curettage) may have scar tissue or adhesions that physically limit how much the lining can expand.
Other factors that can interfere with growth include:
- Reduced estrogen receptor function. Some women with persistently thin linings have fewer or less responsive estrogen receptors in the endometrium, meaning normal doses of estrogen simply don’t trigger the expected cell growth.
- Poor blood flow to the uterus. Thin linings tend to have higher resistance in the uterine arteries and lower levels of the growth signals that build new blood vessels. Without adequate blood supply, the tissue can’t expand.
- Prior long-term oral contraceptive use. Extended time on birth control pills or certain ovulation-stimulating drugs has been linked to endometrial thinning.
- Uterine conditions. Fibroids, polyps, endometriosis, and chronic low-grade inflammation in the uterine cavity can all disrupt normal lining development.
If your lining is consistently under 7 mm despite escalating estrogen doses, your doctor may investigate these underlying causes rather than simply extending the estrogen phase indefinitely.
What a Typical Timeline Looks Like
Here’s a general sense of how the process unfolds during a medicated FET cycle. On days 1 through 3 of estrogen, not much visible change occurs on ultrasound. The lining is usually 3 to 4 mm at baseline, and growth is just beginning at the cellular level. By days 5 through 7, you can expect measurable thickening, often reaching 5 to 6 mm. The most noticeable growth tends to happen between days 8 and 12, when many women reach 7 mm or more.
Your first monitoring ultrasound is typically scheduled around day 10. If the lining looks good (adequate thickness, trilaminar pattern), your clinic will schedule progesterone start and your transfer date. If it’s not quite there, you may continue Estrace for a few more days, increase the dose, or switch to vaginal administration before rechecking.
Some women reach 8 mm by day 8. Others need 16 to 18 days to get to 7 mm. Both scenarios are within the range of normal. The key factor is reaching the target, not how quickly you get there. Extending your estrogen phase by a few extra days does not appear to reduce the quality of the lining or lower your chances of a successful transfer.